HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Intraocular hemocoagulase in human vitrectomy.

Abstract
A prospective study was performed to establish the effects on the bleeding time and the ocular toxicity of the use of intravitreal hemocoagulase (1 NIH thrombin unit/100 ml in BSS Plus) in patients undergoing vitrectomy. Sixty patients with diabetic retinopathy, penetrating ocular injury or non-diabetic retinal vascular disorder, in whom electroretinograms were recordable, were assigned to a study of Hemocoagulase-BSS Plus versus BSS Plus. The bleeding time was measured after cutting the proliferative attachments to the underlying retina. Intravitreal hemocoagulase significantly reduced the bleeding time, and this reduction of bleeding facilitated the surgery. A washout of hemocoagulase at the completion of the vitrectomy was not carried out. Hemocoagulase in the vitreous cavity assisted in maintaining hemostasis during the first week after diabetic vitrectomy. Postoperative electroretinography data did not show any disadvantage for the hemocoagulase infusate. Clinical study showed no adverse effect on the cornea, lens or visual acuity.
AuthorsS H Kim, Y S Cho, Y J Choi
JournalJapanese journal of ophthalmology (Jpn J Ophthalmol) Vol. 38 Issue 1 Pg. 49-55 ( 1994) ISSN: 0021-5155 [Print] Japan
PMID7933697 (Publication Type: Journal Article)
Chemical References
  • Batroxobin
Topics
  • Adolescent
  • Adult
  • Aged
  • Batroxobin (administration & dosage, adverse effects)
  • Child
  • Diabetic Retinopathy (physiopathology, surgery)
  • Electroretinography
  • Eye Injuries, Penetrating (physiopathology, surgery)
  • Female
  • Hemostasis, Surgical
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Retinal Diseases (physiopathology, surgery)
  • Retinal Hemorrhage (etiology, prevention & control)
  • Vitrectomy (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: